Craig A Tooman - Net Worth and Insider Trading
Craig A Tooman Net Worth
The estimated net worth of Craig A Tooman is at least $380,673 dollars as of 2024-11-29. Craig A Tooman is the CHIEF FINANCIAL OFFICER of Aratana Therapeutics Inc and owns about 75,024 shares of Aratana Therapeutics Inc (PETX) stock worth over $369,118. Craig A Tooman is also the Exec VP Finance, CFO of Enzon Pharmaceuticals Inc and owns about 160,480 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $11,555. Details can be seen in Craig A Tooman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig A Tooman has not made any transactions after 2018-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig A Tooman
Craig A Tooman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig A Tooman owns 3 companies in total, including Aratana Therapeutics Inc (PETX) , InSite Vision Inc (INSV) , and Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Craig A Tooman’s form 4 insider trades.
Insider Ownership Summary of Craig A Tooman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2019-07-18 | director & President and CEO |
| INSV | InSite Vision Inc | 2015-11-02 | director |
| ENZN | Enzon Pharmaceuticals Inc | 2010-06-18 | Exec VP Finance & CFO |
Craig A Tooman Latest Holdings Summary
Craig A Tooman currently owns a total of 2 stocks. Among these stocks, Craig A Tooman owns 75,024 shares of Aratana Therapeutics Inc (PETX) as of January 11, 2018, with a value of $369,118 and a weighting of 96.96%. Craig A Tooman also owns 160,480 shares of Enzon Pharmaceuticals Inc (ENZN) as of June 18, 2010, with a value of $11,555 and a weighting of 3.04%.
Latest Holdings of Craig A Tooman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PETX | Aratana Therapeutics Inc | 2018-01-11 | 75,024 | 4.92 | 369,118 |
| ENZN | Enzon Pharmaceuticals Inc | 2010-06-18 | 160,480 | 0.07 | 11,555 |
Holding Weightings of Craig A Tooman
Craig A Tooman Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig A Tooman has made a total of 0 transactions in Aratana Therapeutics Inc (PETX) over the past 5 years. The most-recent trade in Aratana Therapeutics Inc is the sale of 30,000 shares on January 11, 2018, which brought Craig A Tooman around $158,100.
According to the SEC Form 4 filings, Craig A Tooman has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the sale of 123,100 shares on June 18, 2010, which brought Craig A Tooman around $1 Million.
Insider Trading History of Craig A Tooman
- 1
Craig A Tooman Trading Performance
GuruFocus tracks the stock performance after each of Craig A Tooman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig A Tooman is -6.15%. GuruFocus also compares Craig A Tooman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig A Tooman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig A Tooman's insider trading performs compared to the benchmark.
Performance of Craig A Tooman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.67 | | | | | |
| Relative Return to S&P 500(%) | 9.79 | | | | | |
Craig A Tooman Ownership Network
Craig A Tooman Owned Company Details
What does Aratana Therapeutics Inc do?
Who are the key executives at Aratana Therapeutics Inc?
Craig A Tooman is the director & President and CEO of Aratana Therapeutics Inc. Other key executives at Aratana Therapeutics Inc include 10 percent owner Broadfin Healthcare Master Fund Ltd , 10 percent owner Broadfin Capital, Llc , and 10 percent owner Kevin Kotler .
Aratana Therapeutics Inc (PETX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aratana Therapeutics Inc (PETX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aratana Therapeutics Inc (PETX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aratana Therapeutics Inc (PETX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aratana Therapeutics Inc Insider Transactions
Craig A Tooman Mailing Address
Above is the net worth, insider trading, and ownership report for Craig A Tooman. Currently GuruFocus does not have mailing address information for Craig A Tooman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
